Drug Information

Drug General Information
Drug ID
D00CQQ
Former ID
DIB016572
Drug Name
TGFK09SD-ER
Indication Hypoactive sexual desire disorder [ICD10:F52.0] Phase 2 [550647]
Company
Fabre Kramer Pharmaceuticals Inc
Target and Pathway
Target(s) 5-hydroxytryptamine 1A receptor Target Info Modulator [549115]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Serotonergic synapse
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (i) signalling events
WikiPathways Serotonin HTR1 Group and FOS Pathway
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 550647Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.
Ref 549115Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032503)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.